• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大利什曼原虫生长行为的表征:一种用于重组蛋白的新表达系统

Characterization of the growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins.

作者信息

Fritsche Claudia, Sitz Mandy, Weiland Norman, Breitling Reinhard, Pohl Hans-Dieter

机构信息

Department of Medical Engineering and Biotechnology, University of Applied Sciences Jena, Jena, Germany.

出版信息

J Basic Microbiol. 2007 Oct;47(5):384-93. doi: 10.1002/jobm.200710111.

DOI:10.1002/jobm.200710111
PMID:17910102
Abstract

Biotechnological production of recombinant proteins for human therapy requires a cultivation of the host organism in a nutrient medium free of animal substances. Therefore, various nutrient media for the new expression system Leishmania tarentolae were developed and examined according to their cultivation conditions as static suspension culture and agitated culture. Investigations resulted in the development of a serum-free but hemin containing medium, based on yeast extract and buffer salts. Here we report that a high and stable specific growth rate of 0.103 h(-1) and a maximal cell density of 1 x 10(9) cells ml(-1) is obtained in an alternative medium, the YE-medium. For the newly developed medium, the successful expression of enhanced green fluorescent protein and the adaptation of the cultivation from the agitated culture to the bioreactor could be shown. Furthermore, an analytical method for detection of the essential, organic iron source hemin was established. The consumption of hemin was monitored because hemin is a potentially important process parameter for bioprocess control. With knowledge of these results, an improved expression system is available as an alternative to commonly used cell cultures for the production of recombinant proteins.

摘要

用于人类治疗的重组蛋白的生物技术生产需要在不含动物成分的营养培养基中培养宿主生物体。因此,针对新的表达系统——大利什曼原虫,开发了各种营养培养基,并根据其在静态悬浮培养和搅拌培养中的培养条件进行了检测。研究结果是基于酵母提取物和缓冲盐开发出了一种不含血清但含有血红素的培养基。在此我们报告,在另一种培养基YE培养基中,可获得0.103 h⁻¹的高且稳定的比生长速率以及1×10⁹个细胞/毫升的最大细胞密度。对于新开发的培养基,可证明增强型绿色荧光蛋白的成功表达以及培养从搅拌培养向生物反应器的适应性。此外,还建立了一种检测必需有机铁源血红素的分析方法。对血红素的消耗进行了监测,因为血红素是生物过程控制中一个潜在的重要过程参数。基于这些结果,一种改进的表达系统可作为生产重组蛋白的常用细胞培养方法的替代方法。

相似文献

1
Characterization of the growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins.大利什曼原虫生长行为的表征:一种用于重组蛋白的新表达系统
J Basic Microbiol. 2007 Oct;47(5):384-93. doi: 10.1002/jobm.200710111.
2
Development of a defined medium for heterologous expression in Leishmania tarentolae.用于在热带利什曼原虫中进行异源表达的限定培养基的开发。
J Basic Microbiol. 2008 Dec;48(6):488-95. doi: 10.1002/jobm.200700389.
3
Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.在原生动物宿主热带利什曼原虫中表达的重组蛋白的同位素标记。
Protein Expr Purif. 2006 Aug;48(2):167-72. doi: 10.1016/j.pep.2006.04.006. Epub 2006 Apr 25.
4
Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.使用BHK - 21细胞和化学成分确定的无蛋白培养基,对膜曝气搅拌罐和高达1000升气升式生物反应器中的生产工艺进行比较。
Biotechnol Prog. 2003 May-Jun;19(3):833-43. doi: 10.1021/bp0257630.
5
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.一种在完全无动物成分条件下于搅拌式生物反应器中培养的Vero细胞中增殖狂犬病病毒的微载体细胞培养工艺。
Vaccine. 2007 May 10;25(19):3879-89. doi: 10.1016/j.vaccine.2007.01.086. Epub 2007 Feb 5.
6
Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae.基于原生动物宿主塔氏利什曼原虫开发一种诱导型蛋白质表达系统。
Protein Expr Purif. 2005 Jul;42(1):37-46. doi: 10.1016/j.pep.2005.03.004. Epub 2005 Mar 25.
7
Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.真核原生动物寄生虫墨西哥利什曼原虫中重组蛋白的生产:综述
Methods Mol Biol. 2012;824:307-15. doi: 10.1007/978-1-61779-433-9_15.
8
Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.用于在无蛋白培养基中生产由CHO-K1细胞表达的重组MUC1融合蛋白的生物工艺开发。
J Biotechnol. 2004 May 13;110(1):51-62. doi: 10.1016/j.jbiotec.2003.12.008.
9
Enhancement of transient gene expression by fed-batch culture of HEK 293 EBNA1 cells in suspension.通过悬浮培养HEK 293 EBNA1细胞的补料分批培养提高瞬时基因表达。
Biotechnol Lett. 2006 Jun;28(11):843-8. doi: 10.1007/s10529-006-9010-1. Epub 2006 Jun 3.
10
The production of recombinant human laminin-332 in a Leishmania tarentolae expression system.在大利什曼原虫表达系统中重组人层粘连蛋白-332的生产。
Protein Expr Purif. 2009 Nov;68(1):79-84. doi: 10.1016/j.pep.2009.07.005. Epub 2009 Jul 14.

引用本文的文献

1
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens.地中海利什曼原虫作为生产抗病毒病原体疫苗的平台。
NPJ Vaccines. 2024 Nov 6;9(1):212. doi: 10.1038/s41541-024-01005-9.
2
A Modular Cloning Toolkit for the production of recombinant proteins in .用于在……中生产重组蛋白的模块化克隆工具包
Microb Cell. 2024 Apr 30;11:128-142. doi: 10.15698/mic2024.04.821. eCollection 2024.
3
Expression and functional characterization of chimeric recombinant bovine follicle-stimulating hormone produced in Leishmania tarentolae.
在巴尔通体属利什曼原虫中表达和功能表征嵌合重组牛促卵泡素。
Microb Biotechnol. 2024 Apr;17(4):e14444. doi: 10.1111/1751-7915.14444.
4
Heterologous Expression of Human IFNγ and Anti-IL17 Antibody in Leishmania tarentolae Promastigote.在利什曼原虫前鞭毛体中异源表达人 IFNγ 和抗 IL17 抗体。
Acta Parasitol. 2024 Jun;69(2):1107-1114. doi: 10.1007/s11686-024-00822-1. Epub 2024 Mar 27.
5
Evaluation of a Novel Multi-Epitope Peptide Vaccine Candidate from LACK, LeIF, GP63, SMT Antigens of in BALB/c Mice.新型多表位肽疫苗候选物对 BALB/c 小鼠中 LACK、LeIF、GP63、SMT 抗原的评价。
Arch Razi Inst. 2022 Dec 31;77(6):2223-2233. doi: 10.22092/ARI.2022.358499.2238. eCollection 2022 Dec.
6
Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections.利什曼原虫:一种以树突状细胞为靶点的疫苗平台,也是针对利什曼病和病毒感染的下一代疫苗研究的替代病原体。
Parasit Vectors. 2023 Jan 26;16(1):35. doi: 10.1186/s13071-023-05651-1.
7
The Influence of Different Culture Media on the Growth and Recombinant Protein Production of Iranian Lizard Leishmania Promastigote.不同培养基对伊朗蜥蜴利什曼原鞭毛虫前鞭毛体生长及重组蛋白产生的影响
Iran J Parasitol. 2022 Oct-Dec;17(4):543-553. doi: 10.18502/ijpa.v17i4.11282.
8
Epidemic Preparedness- as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19.疫情防范——作为一种易于操作的病毒诊断抗原生产工具:在新冠疫情中的应用
Front Microbiol. 2021 Dec 13;12:736530. doi: 10.3389/fmicb.2021.736530. eCollection 2021.
9
Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum.利什曼原虫寄生虫:新型无血清培养基作为胎牛血清替代品的影响。
Iran Biomed J. 2021 Sep 1;25(5):349-58. doi: 10.52547/ibj.25.5.349. Epub 2021 Aug 29.
10
analysis and expression of a new chimeric antigen as a vaccine candidate against cutaneous leishmaniasis.一种新型嵌合抗原作为抗皮肤利什曼病疫苗候选物的分析与表达
Iran J Basic Med Sci. 2020 Nov;23(11):1409-1418. doi: 10.22038/ijbms.2020.45394.10561.